Literature DB >> 28842394

Transforming Growth Factor-β1/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated Gq-Calcium Signaling.

Hendrik Ungefroren1, David Witte2, Koichiro Mihara2, Bernhard H Rauch2, Petra Henklein2, Olaf Jöhren2, Shirin Bonni2, Utz Settmacher2, Hendrik Lehnert2, Morley D Hollenberg2, Roland Kaufmann2, Frank Gieseler2.   

Abstract

Transforming growth factor-β (TGF-β), serine proteinases such as trypsin, and proteinase-activated receptor 2 (PAR2) promote tumor development by stimulating invasion and metastasis. Previously, we found that in cancer cells derived from pancreatic ductal adenocarcinoma (PDAC) PAR2 protein is necessary for TGF-β1-dependent cell motility. Here, we show in the same cells that, conversely, the type I TGF-β receptor activin receptor-like kinase 5 is dispensable for trypsin and PAR2 activating peptide (PAR2-AP)-induced migration. To reveal whether Gq-calcium signaling is a prerequisite for PAR2 to enhance TGF-β signaling, we investigated the effects of PAR2-APs, PAR2 mutation and PAR2 inhibitors on TGF-β1-induced migration, reporter gene activity, and Smad activation. Stimulation of cells with PAR2-AP alone failed to enhance basal or TGF-β1-induced C-terminal phosphorylation of Smad3, Smad-dependent activity of a luciferase reporter gene, and cell migration. Consistently, in complementary loss of function studies, abrogation of the PAR2-Gq-calcium signaling arm failed to suppress TGF-β1-induced cell migration, reporter gene activity, and Smad3 activation. Together, our findings suggest that the calcium-regulating motif is not required for PAR2 to synergize with TGF-β1 to promote cell motility. Additional experiments in PDAC cells revealed that PAR2 and TGF-β1 synergy may involve TGF-β1 induction of enzymes that cause autocrine cleavage/activation of PAR2, possibly through a biased signaling function. Our results suggest that although reducing PAR2 protein expression may potentially block TGF-β's prooncogenic function, inhibiting PAR2-Gq-calcium signaling alone would not be sufficient to achieve this effect.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28842394     DOI: 10.1124/mol.117.109017

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.

Authors:  Nguyen Huu Tu; Dane D Jensen; Bethany M Anderson; Elyssa Chen; Nestor N Jimenez-Vargas; Nicole N Scheff; Kenji Inoue; Hung D Tran; John C Dolan; Tamaryn A Meek; Morley D Hollenberg; Cheng Z Liu; Stephen J Vanner; Malvin N Janal; Nigel W Bunnett; Laura E Edgington-Mitchell; Brian L Schmidt
Journal:  J Neurosci       Date:  2020-11-10       Impact factor: 6.167

2.  The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.

Authors:  Hendrik Ungefroren; David Witte; Christian Fiedler; Thomas Gädeken; Roland Kaufmann; Hendrik Lehnert; Frank Gieseler; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

Review 3.  Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.

Authors:  Hendrik Ungefroren; David Witte; Bernhard H Rauch; Utz Settmacher; Hendrik Lehnert; Frank Gieseler; Roland Kaufmann
Journal:  Int J Mol Sci       Date:  2017-11-22       Impact factor: 5.923

4.  RAC1B Suppresses TGF-β-Dependent Chemokinesis and Growth Inhibition through an Autoregulatory Feed-Forward Loop Involving PAR2 and ALK5.

Authors:  Hannah Otterbein; Koichiro Mihara; Morley D Hollenberg; Hendrik Lehnert; David Witte; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

5.  Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis.

Authors:  Fatima Abji; Mozhgan Rasti; Alejandro Gómez-Aristizábal; Carla Muytjens; Mahmoud Saifeddine; Koichiro Mihara; Majid Motahhari; Rajiv Gandhi; Sowmya Viswanathan; Morley D Hollenberg; Katerina Oikonomopoulou; Vinod Chandran
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 6.  The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling.

Authors:  Hendrik Ungefroren; Ulrich F Wellner; Tobias Keck; Hendrik Lehnert; Jens-Uwe Marquardt
Journal:  Cancers (Basel)       Date:  2020-11-22       Impact factor: 6.639

Review 7.  Diversification of PAR signaling through receptor crosstalk.

Authors:  Irene Lee-Rivera; Edith López; Ana María López-Colomé
Journal:  Cell Mol Biol Lett       Date:  2022-09-10       Impact factor: 8.702

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.